News - Vaccinogen Vaccinogen Announces Filing of Oncavert® Patent Application Establishing a Concept and Pathway to the Development of an Adenocarcinoma Prevention Vaccine Thu, 16 Jun 2016 11:32:00 -0400 Vaccinogen Believes That Its "Whole-Tumor Methodology" and Focus on "Cancer Heterogeneity" is Supported by Research Published in The Proceedings of the National Academy of Sciences (PNAS) Peer-Reviewed Article Concludes That Extreme Intratumor Diversity, Even in Small Tumors, Suggests a Need to Reevaluate Treatment Strategies Wed, 02 Dec 2015 10:32:00 -0500 Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer Dr. Morsing to Lead Vaccinogen's Clinical, Logistical, Manufacturing and Business Development Activities Wed, 04 Nov 2015 07:33:00 -0500 Vaccinogen Engages D. Barry Boyd, M.D., M.S., as Senior Oncology Advisor Veteran Medical Oncologist Joins Vaccinogen's Medical Advisory Board to Advance its Promising Immunotherapies Wed, 28 Oct 2015 07:33:00 -0400 Vaccinogen Appoints Michael G. Hagerman to its Board of Directors Tue, 06 Oct 2015 07:33:00 -0400 Vaccinogen Enhances Patient-Derived Antibody Program with Revolutionary High-Throughput Single Cell Screening and Analysis System Secures Option Agreement with Dublin City University to Acquire DiCAST Platform Wed, 09 Sep 2015 07:30:00 -0400 Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board Benjamin S. Carson, Sr., MD Steps Down from Board of Directors, Chairman Role and Medical Advisory Board to Focus on His Candidacy for the Republican Presidential Nomination Tue, 05 May 2015 07:00:00 -0400 Vaccinogen Relocates Corporate Headquarters to Baltimore Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial Tue, 24 Feb 2015 07:00:00 -0500 Vaccinogen Elects Ronald Kaiser to Board of Directors Entrepreneur and executive leader brings more than 35 years of financial and accounting expertise to company Tue, 17 Feb 2015 07:00:00 -0500 Vaccinogen Elects Håkan Edström to Board of Directors Established business leader brings more than 40 years of pharmaceutical operations and commercialization expertise to the company Tue, 10 Feb 2015 07:00:00 -0500